» Articles » PMID: 32220650

Clinical and Epidemiological Features of 36 Children with Coronavirus Disease 2019 (COVID-19) in Zhejiang, China: an Observational Cohort Study

Overview
Date 2020 Mar 30
PMID 32220650
Citations 597
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since December, 2019, an outbreak of coronavirus disease 2019 (COVID-19) has spread globally. Little is known about the epidemiological and clinical features of paediatric patients with COVID-19.

Methods: We retrospectively retrieved data for paediatric patients (aged 0-16 years) with confirmed COVID-19 from electronic medical records in three hospitals in Zhejiang, China. We recorded patients' epidemiological and clinical features.

Findings: From Jan 17 to March 1, 2020, 36 children (mean age 8·3 [SD 3·5] years) were identified to be infected with severe acute respiratory syndrome coronavirus 2. The route of transmission was by close contact with family members (32 [89%]) or a history of exposure to the epidemic area (12 [33%]); eight (22%) patients had both exposures. 19 (53%) patients had moderate clinical type with pneumonia; 17 (47%) had mild clinical type and either were asymptomatic (ten [28%]) or had acute upper respiratory symptoms (seven [19%]). Common symptoms on admission were fever (13 [36%]) and dry cough (seven [19%]). Of those with fever, four (11%) had a body temperature of 38·5°C or higher, and nine (25%) had a body temperature of 37·5-38·5°C. Typical abnormal laboratory findings were elevated creatine kinase MB (11 [31%]), decreased lymphocytes (11 [31%]), leucopenia (seven [19%]), and elevated procalcitonin (six [17%]). Besides radiographic presentations, variables that were associated significantly with severity of COVID-19 were decreased lymphocytes, elevated body temperature, and high levels of procalcitonin, D-dimer, and creatine kinase MB. All children received interferon alfa by aerosolisation twice a day, 14 (39%) received lopinavir-ritonavir syrup twice a day, and six (17%) needed oxygen inhalation. Mean time in hospital was 14 (SD 3) days. By Feb 28, 2020, all patients were cured.

Interpretation: Although all paediatric patients in our cohort had mild or moderate type of COVID-19, the large proportion of asymptomatic children indicates the difficulty in identifying paediatric patients who do not have clear epidemiological information, leading to a dangerous situation in community-acquired infections.

Funding: Ningbo Clinical Research Center for Children's Health and Diseases, Ningbo Reproductive Medicine Centre, and Key Scientific and Technological Innovation Projects of Wenzhou.

Citing Articles

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort.

Paroczai D, Bikov A, Blidaru A, Bobu E, Lascu A, Mot C Front Cell Infect Microbiol. 2025; 14:1496176.

PMID: 39885967 PMC: 11779713. DOI: 10.3389/fcimb.2024.1496176.


Significance of supervision sampling in control of communicable respiratory disease simulated by a new model during different stages of the disease.

Houssou Hounye A, Pan X, Zhao Y, Cao C, Wang J, Venunye A Sci Rep. 2025; 15(1):3787.

PMID: 39885197 PMC: 11782622. DOI: 10.1038/s41598-025-86739-9.


Twenty-Five Years of Evolution and Hurdles in Electronic Health Records and Interoperability in Medical Research: Comprehensive Review.

Shen Y, Yu J, Zhou J, Hu G J Med Internet Res. 2025; 27:e59024.

PMID: 39787599 PMC: 11757985. DOI: 10.2196/59024.


Safety of BNT162b2 COVID-19 Vaccine in Adolescent Patients of UP-PGH.

Casis Hao R, Castor M Acta Med Philipp. 2024; 57(11):5-11.

PMID: 39484062 PMC: 11522351. DOI: 10.47895/amp.vi0.6172.


SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature.

Livieratos A, Gogos C, Akinosoglou K Viruses. 2024; 16(8).

PMID: 39205196 PMC: 11359867. DOI: 10.3390/v16081222.


References
1.
Wang Z, Li X, Li D, Li Y . Clinical features of 167 children with the novel influenza A (H1N1) virus infection in Xi'an, China. Turk J Pediatr. 2012; 54(2):99-104. View

2.
Dagan R, Bhutta Z, de Quadros C, Garau J, Klugman K, Khuri-Bulos N . The remaining challenge of pneumonia: the leading killer of children. Pediatr Infect Dis J. 2010; 30(1):1-2. DOI: 10.1097/INF.0b013e3182005389. View

3.
Tang B, Bragazzi N, Li Q, Tang S, Xiao Y, Wu J . An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020; 5:248-255. PMC: 7029158. DOI: 10.1016/j.idm.2020.02.001. View

4.
Wu P, Hao X, Lau E, Wong J, Leung K, Wu J . Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020; 25(3). PMC: 6988272. DOI: 10.2807/1560-7917.ES.2020.25.3.2000044. View

5.
Chen Z, Fu J, Shu Q, Wang W, Chen Y, Hua C . [Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020; 49(2):139-146. PMC: 8800665. DOI: 10.3785/j.issn.1008-9292.2020.02.01. View